The campaign to save MICRA recently released a report that raises serious doubts about implementation of a key provision of California’s Controlled Substance Utilization Review and Evaluation System (CURES) in the trial lawyers’ proposed anti-MICRA ballot measure. According to the report, the ballot measure would put physicians and pharmacists in the impossible position of choosing between either denying or delaying needed prescription medication to legitimately suffering patients, or violating the law.

In addition to more than quadrupling MICRA's cap on non-economic damages, the trial attorneys' proposed initiative would require licensed health care practitioners and pharmacists to consult the CURES database prior to prescribing or dispensing any Schedule II or Schedule III controlled substances to patients.
The non-partisan report found that although this system has the potential to allow prescribing health care providers to check on the relevant prescription drug histories of their patients as required by the proposed initiative, in practice it lacks important functionality needed to allow doctors and other prescribing health care providers to comply. According to the report, the CURES database would be unable to accommodate the more than 200,000 new users that would need to be added in order for the system to be universally utilized, and causing physicians to be legally required to use a database that would not be available.